Nachrichten zur Veru Aktie

Veru (VERU) Soars: Stock Adds 6.9% in Session

Veru (VERU) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes....…

Veru Enrolls First Patient in Phase 2 Clinical Trial of Novel Drug, VERU-111, to Combat COVID-19

--VERU-111 has potential to treat both the SARS-CoV-2 virus infection and the severe inflammation leading to acute respiratory distress syndrome--…

Veru (VERU) Presents At Jefferies Virtual Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru to Present at Jefferies Virtual Healthcare Conference on June 2nd

MIAMI, May 26, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with…

Veru Inc. (VERU) CEO Mitchell Steiner on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Inc. (VERU) Q2 2020 Earnings Call Transcript

VERU earnings call for the period ending March 31, 2020....…

Why Veru Stock Is Vaulting Higher Today

Investors liked the drugmakers positive Q1 update. And they liked its news about a COVID-19 clinical study even more....…

Veru Reports Strong Fiscal 2020 Second Quarter Results as Net Revenues Increase 43%, Gross Profit Up 61%

--Strong Clinical Progress in Advanced Prostate Cancer: VERU-111 Demonstrates Safety and Evidence of Antitumor Activity with Durable PSA Declines and…

Veru EPS beats by $0.02, misses on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing to Pivotal Phase 3 Clinical Program

            --VERU-111 Safe and Well Tolerated at Daily Doses 63 mg and Lower; No Significant Neutropenia…

Veru Inc. (VERU) CEO Mitchell Steiner on Q1 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Veru Continues Strong Positive Sales Momentum in Fiscal 2020 First Quarter; Net Revenues Increase 66%, Gross Profit Up 57%

--Completion of VERU-111 Phase 1b Clinical Trial and Initiation of Phase 2 Prostate Cancer Clinical Trial in Q2 FY 2020--…

Veru EPS misses by $0.03, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Palisades Veru on coronavirus: "I dont think its going to impair economies around the world"

Dan Veru, co-chairman and chief investment officer at Palisade Capital Management, on the economic implications of the coronavirus as the…

Veru Announces Acceptance of Two Abstracts for Presentation at the Genitourinary Cancer Symposium in February 2020

MIAMI , Jan. 21, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), The Prostate Cancer Company, an oncology…

Veru says drug reduces hot flashes in men in mid-stage study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Verus experimental drug reduces hot flashes in men in mid-stage study

Veru Inc said on Monday a higher dose of its experimental drug reduced hot flashes in men with advanced prostate cancer after…

Veru Announces Positive Top-Line Interim Data from Phase 2 Clinical Trial of Zuclomiphene to Treat Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy

-- Plans to Advance Zuclomiphene into Pivotal Phase 3 Clinical Trial in First Half of 2020 -- -- Potential to…